In the recent spark presentation there seemed to be an additional dot point under the section for burns phase 1/2.
"Domestic and International interest in study and study site expansion progressing, with expected advancement Q1 2023"
If I'm not mistaken this would indicate there are about to be developments in this trial apparently within this quarter. Maybe this will be the trigger for the share price boost we currently need. I am so ready to gear some good news on this trial after those awesome initial results over a year ago now.
Ann: Recce Selects CMAX for Phase I/II UTI Clinical Trial, page-27
Add RCE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
48.5¢ |
Change
-0.015(3.00%) |
Mkt cap ! $112.3M | |||
| Open | High | Low | Value | Volume |
| 49.5¢ | 51.5¢ | 48.5¢ | $10.74K | 21.80K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 15892 | 48.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 50.5¢ | 230 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| RCE (ASX) Chart |